▶ 調査レポート

ダルベポエチンアルファの世界市場レポート2020

• 英文タイトル:Global Darbepoetin Alfa Sales Market Report 2020

QYResearchが調査・発行した産業分析レポートです。ダルベポエチンアルファの世界市場レポート2020 / Global Darbepoetin Alfa Sales Market Report 2020 / 20QY06-02288資料のイメージです。• レポートコード:20QY06-02288
• 出版社/出版日:QYResearch / 2020年6月1日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、135ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:医薬品・医療
• 販売価格(消費税別)
  Single User¥592,000 (USD4,000)▷ お問い合わせ
  Multi User¥888,000 (USD6,000)▷ お問い合わせ
  Enterprise License¥1,184,000 (USD8,000)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社の当調査資料では、ダルベポエチンアルファのグローバル市場について種類別(エポジエン、プロクリット、アラネスプ、その他)、用途別(慢性腎臓病患者、がん患者、その他)、地域別(北米、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2015年~2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。

・ダルベポエチンアルファ市場の概要
・世界の主要地域別ダルベポエチンアルファ市場規模2015-2026
・主要プレイヤーの競争状況・市場シェア
・世界のダルベポエチンアルファ市場規模2015-2026:種類別(エポジエン、プロクリット、アラネスプ、その他)
・世界のダルベポエチンアルファ市場規模2015-2026:用途別(慢性腎臓病患者、がん患者、その他)
・ダルベポエチンアルファの北米市場規模2015-2020
・ダルベポエチンアルファのヨーロッパ市場規模2015-2020
・ダルベポエチンアルファの中国市場規模2015-2020
・ダルベポエチンアルファの日本市場規模2015-2020
・ダルベポエチンアルファの東南アジア市場規模2015-2020
・ダルベポエチンアルファのインド市場規模2015-2020
・主要プレイヤーの企業情報:事業概要・売上・企業動向
(Amgen、Johnson & Johnson、Kyowa Hakko Kirin、Novartis、3SBio)
・ダルベポエチンアルファの製造コスト分析
・販売チャネル、流通業者、顧客
・ダルベポエチンアルファの市場動向・機会・課題
・調査の結論

A recently published report by QY Research titled Global Darbepoetin Alfa Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Darbepoetin Alfa market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Darbepoetin alfa (INN) is a re-engineered form of erythropoietin containing 5 amino acid changes (N30, T32, V87, N88, T90) resulting in the creation of 2 new sites for N-linked carbohydrate addition. It has a 3-fold longer serum half-life compared to epoetin alpha and epoetin beta. It stimulates erythropoiesis (increases red blood cell levels) by the same mechanism as rHuEpo (binding and activating the Epo receptor) and is used to treat anemia, commonly associated with chronic renal failure and cancer chemotherapy.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Darbepoetin Alfa market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Darbepoetin Alfa industry.
Based on our recent survey, we have several different scenarios about the Darbepoetin Alfa YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 5229.2 million in 2019. The market size of Darbepoetin Alfa will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Darbepoetin Alfa market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Darbepoetin Alfa market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Darbepoetin Alfa market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Darbepoetin Alfa market. The report also includes nautical information, where it shows Darbepoetin Alfa market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Darbepoetin Alfa market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Darbepoetin Alfa market.
The classification of Darbepoetin Alfa includes Epogen, Procrit, Aranesp and others, and the proportion of Epogen in 2017 is about 45%.
Darbepoetin Alfa is widely used for Patients with Chronic Kidney Disease, Patients with Cancer others. The most proportion of Darbepoetin Alfa is used for the Patients with Chronic Kidney Disease, and the proportion in 2017 is 62%.
North America is the largest consumption place, with a consumption market share nearly 47% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 41%.
Geographical Analysis:
Based on region, the global Darbepoetin Alfa market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Darbepoetin Alfa market are
Amgen
Johnson & Johnson
Kyowa Hakko Kirin
Novartis
3SBio

Segment by Type
Epogen
Procrit
Aranesp
Others
Segment by Application
Patients with Chronic Kidney Disease
Patients with Cancer
Others
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Darbepoetin Alfa market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Darbepoetin Alfa market.
• The market share of the global Darbepoetin Alfa market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Darbepoetin Alfa market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Darbepoetin Alfa market.

レポート目次

1 Darbepoetin Alfa Market Overview
1.1 Darbepoetin Alfa Product Scope
1.2 Darbepoetin Alfa Segment by Type
1.2.1 Global Darbepoetin Alfa Sales by Type (2020-2026)
1.2.2 Epogen
1.2.3 Procrit
1.2.4 Aranesp
1.2.5 Others
1.3 Darbepoetin Alfa Segment by Application
1.3.1 Global Darbepoetin Alfa Sales Comparison by Application (2020-2026)
1.3.2 Patients with Chronic Kidney Disease
1.3.3 Patients with Cancer
1.3.4 Others
1.4 Darbepoetin Alfa Market Estimates and Forecasts (2015-2026)
1.4.1 Global Darbepoetin Alfa Sales Growth Rate (2015-2026)
1.4.2 Global Darbepoetin Alfa Revenue and Growth Rate (2015-2026)
1.4.3 Global Darbepoetin Alfa Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Darbepoetin Alfa Industry Impact
1.5.1 How the Covid-19 is Affecting the Darbepoetin Alfa Industry
1.5.1.1 Darbepoetin Alfa Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Darbepoetin Alfa Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Darbepoetin Alfa Players to Combat Covid-19 Impact

2 Darbepoetin Alfa Estimate and Forecast by Region
2.1 Global Darbepoetin Alfa Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Darbepoetin Alfa Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Darbepoetin Alfa Sales Market Share by Region (2015-2020)
2.2.2 Global Darbepoetin Alfa Revenue Market Share by Region (2015-2020)
2.3 Global Darbepoetin Alfa Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Darbepoetin Alfa Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Darbepoetin Alfa Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Darbepoetin Alfa Estimates and Projections (2015-2026)
2.4.2 Europe Darbepoetin Alfa Estimates and Projections (2015-2026)
2.4.3 China Darbepoetin Alfa Estimates and Projections (2015-2026)
2.4.4 Japan Darbepoetin Alfa Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Darbepoetin Alfa Estimates and Projections (2015-2026)
2.4.6 India Darbepoetin Alfa Estimates and Projections (2015-2026)
3 Global Darbepoetin Alfa Competition Landscape by Players
3.1 Global Top Darbepoetin Alfa Players by Sales (2015-2020)
3.2 Global Top Darbepoetin Alfa Players by Revenue (2015-2020)
3.3 Global Darbepoetin Alfa Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Darbepoetin Alfa as of 2019)
3.4 Global Darbepoetin Alfa Average Price by Company (2015-2020)
3.5 Manufacturers Darbepoetin Alfa Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Darbepoetin Alfa Players (Opinion Leaders)
4 Global Darbepoetin Alfa Market Size by Type
4.1 Global Darbepoetin Alfa Historic Market Review by Type (2015-2020)
4.1.1 Global Darbepoetin Alfa Sales Market Share by Type (2015-2020)
4.1.2 Global Darbepoetin Alfa Revenue Market Share by Type (2015-2020)
4.1.3 Global Darbepoetin Alfa Price by Type (2014-2020)
4.2 Global Darbepoetin Alfa Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Darbepoetin Alfa Sales Forecast by Type (2021-2026)
4.2.2 Global Darbepoetin Alfa Revenue Forecast by Type (2021-2026)
4.2.3 Global Darbepoetin Alfa Price Forecast by Type (2021-2026)
5 Global Darbepoetin Alfa Market Size by Application
5.1 Global Darbepoetin Alfa Historic Market Review by Application (2015-2020)
5.1.1 Global Darbepoetin Alfa Sales Market Share by Application (2015-2020)
5.1.2 Global Darbepoetin Alfa Revenue Market Share by Application (2015-2020)
5.1.3 Global Darbepoetin Alfa Price by Application (2015-2020)
5.2 Global Darbepoetin Alfa Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Darbepoetin Alfa Sales Forecast by Application (2021-2026)
5.2.2 Global Darbepoetin Alfa Revenue Forecast by Application (2021-2026)
5.2.3 Global Darbepoetin Alfa Price Forecast by Application (2021-2026)

3 North America Darbepoetin Alfa Market Facts & Figures
3.2 North America Darbepoetin Alfa Sales Market Share by Company (2015-2020)
3.3 North America Darbepoetin Alfa Sales Market Share by Type (2015-2020)
3.4 North America Darbepoetin Alfa Sales Market Share by Application (2015-2020)

4 Europe Darbepoetin Alfa Market Facts & Figures
4.2 Europe Darbepoetin Alfa Sales Market Share by Company (2015-2020)
4.3 Europe Darbepoetin Alfa Sales Market Share by Type (2015-2020)
4.4 Europe Darbepoetin Alfa Sales Market Share by Application (2015-2020)

5 China Darbepoetin Alfa Market Facts & Figures
5.2 China Darbepoetin Alfa Sales Market Share by Company (2015-2020)
5.3 China Darbepoetin Alfa Sales Market Share by Type (2015-2020)
5.4 China Darbepoetin Alfa Sales Market Share by Application (2015-2020)

6 Japan Darbepoetin Alfa Market Facts & Figures
6.2 Japan Darbepoetin Alfa Sales Market Share by Company (2015-2020)
6.3 Japan Darbepoetin Alfa Sales Market Share by Type (2015-2020)
6.4 Japan Darbepoetin Alfa Sales Market Share by Application (2015-2020)

7 Southeast Asia Darbepoetin Alfa Market Facts & Figures
7.2 Southeast Asia Darbepoetin Alfa Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Darbepoetin Alfa Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Darbepoetin Alfa Sales Market Share by Application (2015-2020)

8 India Darbepoetin Alfa Market Facts & Figures
8.2 India Darbepoetin Alfa Sales Market Share by Company (2015-2020)
8.3 India Darbepoetin Alfa Sales Market Share by Type (2015-2020)
8.4 India Darbepoetin Alfa Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Darbepoetin Alfa Business
12.1 Amgen
12.1.1 Amgen Darbepoetin Alfa Corporation Information
12.1.2 Amgen Darbepoetin Alfa Business Overview and Total Revenue
12.1.3 Amgen Darbepoetin Alfa Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Amgen Darbepoetin Alfa Products Offered
12.1.5 Amgen Recent Development
12.2 Johnson & Johnson
12.2.1 Johnson & Johnson Darbepoetin Alfa Corporation Information
12.2.2 Johnson & Johnson Darbepoetin Alfa Business Overview and Total Revenue
12.2.3 Johnson & Johnson Darbepoetin Alfa Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Johnson & Johnson Darbepoetin Alfa Products Offered
12.2.5 Johnson & Johnson Recent Development
12.3 Kyowa Hakko Kirin
12.3.1 Kyowa Hakko Kirin Darbepoetin Alfa Corporation Information
12.3.2 Kyowa Hakko Kirin Darbepoetin Alfa Business Overview and Total Revenue
12.3.3 Kyowa Hakko Kirin Darbepoetin Alfa Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Kyowa Hakko Kirin Darbepoetin Alfa Products Offered
12.3.5 Kyowa Hakko Kirin Recent Development
12.4 Novartis
12.4.1 Novartis Darbepoetin Alfa Corporation Information
12.4.2 Novartis Darbepoetin Alfa Business Overview and Total Revenue
12.4.3 Novartis Darbepoetin Alfa Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Novartis Darbepoetin Alfa Products Offered
12.4.5 Novartis Recent Development
12.5 3SBio
12.5.1 3SBio Darbepoetin Alfa Corporation Information
12.5.2 3SBio Darbepoetin Alfa Business Overview and Total Revenue
12.5.3 3SBio Darbepoetin Alfa Sales, Revenue and Gross Margin (2015-2020)
12.5.4 3SBio Darbepoetin Alfa Products Offered
12.5.5 3SBio Recent Development

13 Darbepoetin Alfa Manufacturing Cost Analysis
13.1 Darbepoetin Alfa Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Darbepoetin Alfa
13.4 Darbepoetin Alfa Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Darbepoetin Alfa Distributors List
14.3 Darbepoetin Alfa Customers

15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables
Table 1. Global Darbepoetin Alfa Sales (M Units) Growth Rate by Type (2020-2026)
Table 2. Global Darbepoetin Alfa Sales (M Units) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Darbepoetin Alfa Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Darbepoetin Alfa Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Darbepoetin Alfa Players to Combat Covid-19 Impact
Table 8. Global Market Darbepoetin Alfa Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Darbepoetin Alfa Sales (M Units) by Region (2015-2020)
Table 10. Global Darbepoetin Alfa Sales Market Share by Region (2015-2020)
Table 11. Global Darbepoetin Alfa Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Darbepoetin Alfa Revenue Share by Region (2015-2020)
Table 13. Global Darbepoetin Alfa Sales (M Units) Forecast by Region (2021-2026)
Table 14. Global Darbepoetin Alfa Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Darbepoetin Alfa Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Darbepoetin Alfa Revenue Share Forecast by Region (2021-2026)
Table 17. Global Darbepoetin Alfa (M Units) of Key Companies (2015-2020)
Table 18. Global Darbepoetin Alfa Sales Share by Company (2015-2020)
Table 19. Global Darbepoetin Alfa Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Darbepoetin Alfa Revenue Share by Company (2015-2020)
Table 21. Global Darbepoetin Alfa by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Darbepoetin Alfa as of 2019)
Table 22. Global Darbepoetin Alfa Average Price (USD/Unit) of Key Company (2015-2020)
Table 23. Manufacturers Darbepoetin Alfa Manufacturing Sites and Area Served
Table 24. Manufacturers Darbepoetin Alfa Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Darbepoetin Alfa Players
Table 27. Global Darbepoetin Alfa Sales (M Units) by Type (2015-2020)
Table 28. Global Darbepoetin Alfa Sales Share by Type (2015-2020)
Table 29. Global Darbepoetin Alfa Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Darbepoetin Alfa Price (M Units) by Type (2015-2020)
Table 31. Global Darbepoetin Alfa Sales Share by Type (2021-2026)
Table 32. Global Darbepoetin Alfa Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Darbepoetin Alfa Revenue Share by Type (2021-2026)
Table 34. Global Darbepoetin Alfa Price (M Units) by Type (2021-2026)
Table 35. Global Darbepoetin Alfa Sales (M Units) by Application (2015-2020)
Table 36. Global Darbepoetin Alfa Sales Share by Application (2015-2020)
Table 37. Global Darbepoetin Alfa Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Darbepoetin Alfa Price (M Units) by Application (2015-2020)
Table 39. Global Darbepoetin Alfa Sales (M Units) by Application (2021-2026)
Table 40. Global Darbepoetin Alfa Sales Share by Application (2021-2026)
Table 41. Global Darbepoetin Alfa Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Darbepoetin Alfa Revenue Share by Application (2021-2026)
Table 43. Global Darbepoetin Alfa Price (M Units) by Application (2021-2026)
Table 44. United States Darbepoetin Alfa Sales (M Units) by Company (2015-2020)
Table 45. United States Darbepoetin Alfa Sales Market Share by Company (2015-2020)
Table 46. United States Darbepoetin Alfa Sales (M Units) by Type (2015-2020)
Table 47. United States Darbepoetin Alfa Sales Market Share by Type (2015-2020)
Table 48. United States Darbepoetin Alfa Sales (M Units) by Application (2015-2020)
Table 49. United States Darbepoetin Alfa Sales Market Share by Application (2015-2020)
Table 50. Europe Darbepoetin Alfa Sales (M Units) by Company (2015-2020)
Table 51. Europe Darbepoetin Alfa Sales Market Share by Company (2015-2020)
Table 52. Europe Darbepoetin Alfa Sales (M Units) by Type (2015-2020)
Table 53. Europe Darbepoetin Alfa Sales Market Share by Type (2015-2020)
Table 54. Europe Darbepoetin Alfa Sales (M Units) by Application (2015-2020)
Table 55. Europe Darbepoetin Alfa Sales Market Share by Type (2015-2020)
Table 56. China Darbepoetin Alfa Sales (M Units) by Company (2015-2020)
Table 57. China Darbepoetin Alfa Sales Market Share by Company (2015-2020)
Table 58. China Darbepoetin Alfa Sales (M Units) by Type (2015-2020)
Table 59. China Darbepoetin Alfa Sales Market Share by Type (2015-2020)
Table 60. China Darbepoetin Alfa Sales (M Units) by Application (2015-2020)
Table 61. China Darbepoetin Alfa Sales Market Share by Application (2015-2020)
Table 62. Japan Darbepoetin Alfa Sales (M Units) by Company (2015-2020)
Table 63. Japan Darbepoetin Alfa Sales Market Share by Company (2015-2020)
Table 64. Japan Darbepoetin Alfa Sales (M Units) by Type (2015-2020)
Table 65. Japan Darbepoetin Alfa Sales Market Share by Type (2015-2020)
Table 66. Japan Darbepoetin Alfa Sales (M Units) by Application (2015-2020)
Table 67. Japan Darbepoetin Alfa Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Darbepoetin Alfa Sales (M Units) by Company (2015-2020)
Table 69. Southeast Asia Darbepoetin Alfa Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Darbepoetin Alfa Sales (M Units) by Type (2015-2020)
Table 71. Southeast Asia Darbepoetin Alfa Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Darbepoetin Alfa Sales (M Units) by Type (2015-2020)
Table 73. Southeast Asia Darbepoetin Alfa Sales Market Share by Application (2015-2020)
Table 74. India Darbepoetin Alfa Sales (M Units) by Company (2015-2020)
Table 75. India Darbepoetin Alfa Sales Market Share by Company (2015-2020)
Table 76. India Darbepoetin Alfa Sales (M Units) by Type (2015-2020)
Table 77. India Darbepoetin Alfa Sales Market Share by Type (2015-2020)
Table 78. India Darbepoetin Alfa Sales (M Units) by Application (2015-2020)
Table 79. India Darbepoetin Alfa Sales Market Share by Application (2015-2020)
Table 80. Amgen Corporation Information
Table 81. Amgen Description and Business Overview
Table 82. Amgen Darbepoetin Alfa Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Amgen Darbepoetin Alfa Product
Table 84. Amgen Recent Development
Table 85. Johnson & Johnson Corporation Information
Table 86. Johnson & Johnson Description and Business Overview
Table 87. Johnson & Johnson Darbepoetin Alfa Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Johnson & Johnson Darbepoetin Alfa Product
Table 89. Johnson & Johnson Recent Development
Table 90. Kyowa Hakko Kirin Corporation Information
Table 91. Kyowa Hakko Kirin Description and Business Overview
Table 92. Kyowa Hakko Kirin Darbepoetin Alfa Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Kyowa Hakko Kirin Darbepoetin Alfa Product
Table 94. Kyowa Hakko Kirin Recent Development
Table 95. Novartis Corporation Information
Table 96. Novartis Description and Business Overview
Table 97. Novartis Darbepoetin Alfa Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Novartis Darbepoetin Alfa Product
Table 99. Novartis Recent Development
Table . 3SBio Corporation Information
Table . 3SBio Description and Business Overview
Table . 3SBio Darbepoetin Alfa Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table . 3SBio Darbepoetin Alfa Product
Table . 3SBio Recent Development
Table 105. Production Base and Market Concentration Rate of Raw Material
Table 106. Key Suppliers of Raw Materials
Table 107. Darbepoetin Alfa Distributors List
Table 108. Darbepoetin Alfa Customers List
Table 109. Market Key Trends
Table 110. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 111. Key Challenges
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Darbepoetin Alfa Product Picture
Figure 2. Global Darbepoetin Alfa Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Darbepoetin Alfa Market Share by Application in 2020 & 2026
Figure 6. Patients with Chronic Kidney Disease Examples
Figure 7. Patients with Cancer Examples
Figure 8. Others Examples
Figure 9. Global Darbepoetin Alfa Sales (M Units) Growth Rate (2015-2026)
Figure 10. Global Darbepoetin Alfa Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Darbepoetin Alfa Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 12. Global Darbepoetin Alfa Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Darbepoetin Alfa Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Darbepoetin Alfa Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Darbepoetin Alfa Sales (M Units) Growth Rate (2015-2026)
Figure 16. Europe Darbepoetin Alfa Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Darbepoetin Alfa Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Darbepoetin Alfa Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Darbepoetin Alfa Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Darbepoetin Alfa Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Darbepoetin Alfa Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Darbepoetin Alfa Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Darbepoetin Alfa Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Darbepoetin Alfa Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Darbepoetin Alfa Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Darbepoetin Alfa Players Market Share by Revenue in Darbepoetin Alfa 2015 & 2019
Figure 27. Darbepoetin Alfa Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Darbepoetin Alfa Revenue Share by Type (2015-2020)
Figure 29. Global Darbepoetin Alfa Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Darbepoetin Alfa Revenue Share by Application (2015-2020)
Figure 31. Global Darbepoetin Alfa Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Darbepoetin Alfa Sales Market Share by Type in 2019
Figure 33. United States Darbepoetin Alfa Sales Market Share by Type in 2019
Figure 34. Europe Darbepoetin Alfa Sales Market Share by Company in 2019
Figure 35. Europe Darbepoetin Alfa Sales Market Share by Type in 2019
Figure 36. Europe Darbepoetin Alfa Sales Market Share by Application in 2019
Figure 37. China Darbepoetin Alfa Sales Market Share by Company in 2019
Figure 38. China Darbepoetin Alfa Sales Market Share by Type in 2019
Figure 39. China Darbepoetin Alfa Sales Market Share by Application in 2019
Figure 40. Japan Darbepoetin Alfa Sales Market Share by Company in 2019
Figure 41. Japan Darbepoetin Alfa Sales Market Share by Type in 2019
Figure 42. Japan Darbepoetin Alfa Sales Market Share by Application in 2019
Figure 43. Southeast Asia Darbepoetin Alfa Sales Market Share by Company in 2019
Figure 44. Southeast Asia Darbepoetin Alfa Sales Market Share by Type in 2019
Figure 45. Southeast Asia Darbepoetin Alfa Sales Market Share by Application in 2019
Figure 46. India Darbepoetin Alfa Sales Market Share by Company in 2019
Figure 47. India Darbepoetin Alfa Sales Market Share by Type in 2019
Figure 48. India Darbepoetin Alfa Sales Market Share by Application in 2019
Figure 49. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Kyowa Hakko Kirin Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. 3SBio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Key Raw Materials Price Trend
Figure 55. Manufacturing Cost Structure of Darbepoetin Alfa
Figure 56. Manufacturing Process Analysis of Darbepoetin Alfa
Figure 57. Darbepoetin Alfa Industrial Chain Analysis
Figure 58. Channels of Distribution
Figure 59. Distributors Profiles
Figure 60. Porter's Five Forces Analysis
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed